- Home
- HKIT vs RLYB Comparison
HKIT vs RLYB Comparison
Compare HKIT & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- RLYB
- Stock Information
- Founded
- HKIT 1996
- RLYB 2018
- Country
- HKIT China
- RLYB United States
- Employees
- HKIT N/A
- RLYB N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- RLYB Health Care
- Exchange
- HKIT Nasdaq
- RLYB Nasdaq
- Market Cap
- HKIT 50.1M
- RLYB 46.1M
- IPO Year
- HKIT 2023
- RLYB 2021
- Fundamental
- Price
- HKIT $1.55
- RLYB $1.11
- Analyst Decision
- HKIT
- RLYB Buy
- Analyst Count
- HKIT 0
- RLYB 6
- Target Price
- HKIT N/A
- RLYB $8.30
- AVG Volume (30 Days)
- HKIT 30.7K
- RLYB 50.0K
- Earning Date
- HKIT 11-07-2024
- RLYB 11-07-2024
- Dividend Yield
- HKIT N/A
- RLYB N/A
- EPS Growth
- HKIT N/A
- RLYB N/A
- EPS
- HKIT 0.08
- RLYB N/A
- Revenue
- HKIT $4,563,731.00
- RLYB $299,000.00
- Revenue This Year
- HKIT N/A
- RLYB N/A
- Revenue Next Year
- HKIT N/A
- RLYB N/A
- P/E Ratio
- HKIT $19.61
- RLYB N/A
- Revenue Growth
- HKIT N/A
- RLYB N/A
- 52 Week Low
- HKIT $0.54
- RLYB $1.08
- 52 Week High
- HKIT $6.48
- RLYB $4.60
- Technical
- Relative Strength Index (RSI)
- HKIT 54.47
- RLYB 47.41
- Support Level
- HKIT $1.42
- RLYB $1.09
- Resistance Level
- HKIT $1.74
- RLYB $1.18
- Average True Range (ATR)
- HKIT 0.10
- RLYB 0.04
- MACD
- HKIT 0.02
- RLYB 0.00
- Stochastic Oscillator
- HKIT 51.81
- RLYB 22.22
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.